About Dr. Michael von Bergwelt
Dr. Michael von Bergwelt is a Senior Consultant and academic Medical Oncologist with over 28 years of experience in haematology, medical oncology, and cancer immunotherapy, recognised as one of the top Medical Oncologist specialists in Munich, Germany. His pioneering work in CAR-T cell therapy, checkpoint inhibitors, and bone marrow transplantation has shaped European clinical oncology.
- 28+ years of clinical and academic experience in haematology & medical oncology
- 594+ peer-reviewed publications with 17,000+ academic citations
- Mildred-Scheel Fellowship recipient — German Cancer Aid (Deutsche Krebshilfe)
- EBMT Basic Science Award (2010) and ASH Travel Award recipient
- Consistently ranked among Germany's Top 100 Oncologists by FOCUS magazine
- Pioneer in CAR-T cell therapy & immune checkpoint inhibition for lymphoma
Qualifications & Credentials
Medical Degrees
- Medical Studies — Universities of Münster, Freiburg & Paris (Paris-South XI), 1988–1996
- MSc in Biological & Medical Sciences (Human Biology) — Université Paris-Sud XI, France
- MD (Dissertation) — University of Freiburg, Germany, 1997
Fellowships & Special Training
- Mildred-Scheel Fellowship — German Cancer Aid (Deutsche Krebshilfe)
- Board Certification in Internal Medicine, Haematology & Medical Oncology, Germany
- Board Certification in Emergency Medicine, Lower Saxony, 1999
- Specialised training in Bone Marrow Transplantation & Cellular Immunotherapy
Certifications & Accreditations
- German Medical Council (Ärztekammer) Registration
- Member — German Cancer Consortium (DKTK)
- Member — European Society for Blood and Marrow Transplantation (EBMT)
- Member — Lymphoma Research Foundation of America
Areas of Expertise
Major Conditions Treated
- Acute & Chronic Leukaemia
- Hodgkin & Non-Hodgkin Lymphoma
- Multiple Myeloma
- Bone & Soft Tissue Sarcomas
- Gastrointestinal Cancers (Stomach, Colon, Pancreas, Liver)
- Lung Cancer & Mesothelioma
- Breast Cancer
- Head & Neck Cancers
- Neuroendocrine Tumours
- Cancer of Unknown Primary (CUP)
- Malignant Ascites
Sub-specialties
- Cellular Cancer Immunotherapy & CAR-T: CD19 CAR-T cell therapy for large B-cell lymphoma — recognised as a leading medical oncologist in Munich, Germany for cellular immunotherapy.
- Bone Marrow & Stem Cell Transplantation: Allogeneic and autologous transplantation for haematological malignancies.
- Precision & Molecular Oncology: Molecular tumour board–led personalised treatment for rare and complex cancers — relevant to international patients researching the best medical oncologist doctor in Germany.
Advanced Procedures & Treatments
- CAR-T Cell Therapy (CD19, BCMA)
- Allogeneic & Autologous Stem Cell Transplantation
- Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)
- Bispecific T-cell Engagers (Blinatumomab)
- Targeted Therapy & Molecular Profiling
- Hyperthermia + Chemotherapy (for sarcomas)
- Antibody & Conjugate Therapy
- High-Dose Chemotherapy with Stem Cell Rescue
List of Disease and Treatment for which Dr. Michael von Bergwelt can be consulted
Professional Experience
Current Affiliation
- University Hospital Ludwig-Maximilians-Universität (LMU), Munich, Germany — Director, Medical Clinic and Polyclinic III; Professor & Chair, Department of Medicine III (Haematology, Oncology, BMT) — 2017–Present
Past Affiliations
- University Hospital Cologne, Germany — Senior Consultant & Researcher, Haematology / Oncology (Past)
- University of Freiburg, Germany — Postgraduate clinical & research training (until 1997)
Academic & Research Roles
- Professor & Chair — Internal Medicine with focus on Haematology & Medical Oncology, LMU Munich
- Chairman — German Consortium for Translational Cancer Research (DKTK), since 2020
- Founding member — iCHOP and Nine-I (intensive care for haematology/oncology patients)
- Co-founder — Tabby Therapeutics & Vision Zero (cellular cancer immunotherapy initiatives)
Key Achievements
- 594+ peer-reviewed scientific publications
- 17,000+ citations in international research literature
- 9.80/10 expert rating on AiroMedical international medical platform
- Consistent FOCUS Top 100 Oncologists ranking in Germany
- Leadership of major translational cancer research consortia
Awards & Recognitions
National & International Awards
- Mildred-Scheel Fellowship — German Cancer Aid (Deutsche Krebshilfe)
- Basic Science Award — European Society for Blood and Marrow Transplantation (EBMT), 2010
- Travel Award — American Society of Hematology (ASH)
- FOCUS Top 100 Oncologists in Germany (recurring)
Professional Memberships
- German Cancer Consortium (DKTK)
- European Society for Blood and Marrow Transplantation (EBMT)
- Lymphoma Research Foundation of America
- German José Carreras Leukaemia Foundation
- American Society of Hematology (ASH)
Research & Publications
Published Papers (Selected)
- von Bergwelt-Baildon M, et al. Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma. Multi-centre study.
- Auernhammer C J, von Bergwelt-Baildon M, et al. Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCC Munich LMU Molecular Tumor Board.
- von Bergwelt-Baildon M, et al. Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
- von Bergwelt-Baildon M, et al. Phenotypical and functional characterization of tumor-infiltrating lymphocytes in colorectal carcinoma under stimulation with Interleukin-2 and Interleukin-4 in vitro. MD Dissertation, University of Freiburg, 1997.
- 594+ additional peer-reviewed publications across haematology, oncology, and immunotherapy.
Ongoing Research & Clinical Interests
- B cells in cancer biology and immunotherapy
- CAR-T cell therapy in solid tumours and lymphoma
- Immune checkpoint inhibition in Hodgkin lymphoma
- Precision oncology & molecular tumour boards
- Bispecific T-cell engagers in autoimmune-related haematology
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹15,000 – ₹30,000 | $180 – $360 |
| Chemotherapy (per cycle, regimen-dependent) | ₹1,00,000 – ₹5,00,000 | $1,200 – $6,000 |
| Immunotherapy / Checkpoint Inhibitor (per cycle) | ₹2,50,000 – ₹6,00,000 | $3,000 – $7,200 |
| CAR-T Cell Therapy (per treatment) | ₹2,00,00,000 – ₹3,50,00,000 | $240,000 – $420,000 |
| Allogeneic Stem Cell Transplant | ₹65,00,000 – ₹1,50,00,000 | $78,000 – $180,000 |
| Molecular Tumour Profiling | ₹2,50,000 – ₹6,00,000 | $3,000 – $7,200 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Michael von Bergwelt use in Medical Oncologist treatment?
Dr. Michael von Bergwelt employs cutting-edge oncology technologies including CAR-T cell therapy, immune checkpoint inhibitors (PD-1/PD-L1), bispecific T-cell engagers, allogeneic and autologous stem cell transplantation, hyperthermia-enhanced chemotherapy, and molecular tumour profiling. International patients can request virtual second opinions through Cancer Rounds.
2. What conditions does Dr. Michael von Bergwelt specialize in treating?
As a leading medical oncologist specialist in Munich, Germany, Dr. von Bergwelt treats acute & chronic leukaemia, Hodgkin & non-Hodgkin lymphoma, multiple myeloma, sarcomas, lung cancer, breast cancer, gastrointestinal cancers, mesothelioma, head & neck cancers, and rare cancers like neuroendocrine tumours and CUP — making him one of the best medical oncologist doctors in Germany for complex and refractory cancers.
3. How do I book an appointment with Dr. Michael von Bergwelt?
Appointments with Dr. Michael von Bergwelt can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Michael von Bergwelt?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Michael von Bergwelt, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Michael von Bergwelt offer second opinions for Medical Oncologist cases?
Yes. Second opinion consultations with Dr. Michael von Bergwelt can be arranged via Cancer Rounds for patients seeking expert review of cancer treatment plans, CAR-T eligibility, or transplant options from a Medical Oncologist specialist in Munich, Germany.
University Hospital Rechts der Isar - Germany
Blood Cancer
